A Study in Participants With Non-cirrhotic NASH With Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 26, 2022

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Interventions
DRUG

AZD4831

AZD4831

OTHER

Placebo

Placebo

Trial Locations (65)

1280

Research Site, Ciudad de Buenos Aires

1664

Research Site, Pilar

1714

Research Site, Grålum

2100

Research Site, København Ø

2400

Research Site, København NV

2819

Research Site, Gjøvik

4600

Research Site, Køge

6700

Research Site, Esbjerg

7600

Research Site, Mar del Plata

8200

Research Site, Aarhus N

10126

Research Site, Torino

10701

Research Site, Yonkers

15006

Research Site, A Coruña

20089

Research Site, Rozzano

20122

Research Site, Milan

20132

Research Site, Milan

25198

Research Site, Lleida

28046

Research Site, Madrid

28223

Research Site, Pozuelo de Alarcón

28557

Research Site, Morehead City

29010

Research Site, Málaga

32256

Research Site, Jacksonville

33135

Research Site, Miami

33803

Research Site, Lakeland

33813

Research Site, Lakeland

39008

Research Site, Santander

44210

Research Site, Guadalajara

44340

Research Site, Guadalajara

44670

Research Site, Guadalajara

46014

Research Site, Valencia

64000

Research Site, Monterrey

64460

Research Site, Monterrey

64710

Research Site, Monterrey

71013

Research Site, San Giovanni Rotondo

71100

Research Site, Foggia

75230

Research Site, Dallas

77090

Research Site, Houston

78229

Research Site, San Antonio

85224

Research Site, Chandler

85712

Research Site, Tucson

89109

Research Site, Las Vegas

90277

Research Site, Redondo Beach

91763

Research Site, Montclair

91911

Research Site, Chula Vista

92868

Research Site, Orange

94299

Research Site, Boca del Rio

94305

Research Site, Stanford

95100

Research Site, Catania

C1056ABJ

Research Site, CABA

C1119ACN

Research Site, CABA

C1426

Research Site, CABA

B1704ETD

Research Site, Ramos Mejía

00128

Research Site, Roma

00168

Research Site, Roma

06700

Research Site, Cuauhtémoc

Research Site, Mexico City

014080

Research Site, Mexico City

03330

Research Site, Mexico City

03300

Research Site, México

N-1478

Research Site, Lørenskog

0456

Research Site, Oslo

N-9038

Research Site, Tromsø

1250-189

Research Site, Lisbon

581 85

Research Site, Linköping

751 85

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY